Beyond Quadruple Therapy and Current Therapeutic Strategies in Heart Failure with Reduced Ejection Fraction: Medical Therapies with Potential to Become Part of the Therapeutic Armamentarium.
心臟衰竭伴隨降低射血分數的四重療法之外及目前的治療策略:具潛力成為治療武器庫一部分的藥物治療。
Int J Mol Sci 2024-03-30
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review.
高血壓合併急性和慢性保留射血分數心衰的藥物治療:最新綜述。
Am J Cardiovasc Drugs 2024-04-04
Eligibility and Projected Benefits of Rapid Initiation of Quadruple Medical Therapy for Newly Diagnosed Heart Failure.
新診斷心力衰竭患者快速開始四藥聯合治療的資格和預期效益。
JACC Heart Fail 2024-04-10
Pharmacotherapy in patients with heart failure with reduced ejection fraction: A systematic review and meta-analysis.
心臟衰竭患者降低射出分數的藥物治療:系統性回顧與荟萃分析。
Chin Med J (Engl) 2024-05-29
Distinct Profiles and New Pharmacological Targets for Heart Failure with Preserved Ejection Fraction.
心臟衰竭伴保留射血分數的不同特徵及新藥理靶點。
Rev Cardiovasc Med 2024-08-14
Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?
心臟衰竭伴有減少射出分數的四重療法序列:這真的重要嗎?
Heart Fail Clin 2024-08-31